VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Tuesday, December 30, 2025
Stock Comparison
Nabtesco Corporation vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Nabtesco Corporation
6268 · Tokyo Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nabtesco Corporation's moat claims, evidence, and risks.
View 6268 analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: Nabtesco Corporation leads (91 / 100 vs 71 / 100 for Merck & Co., Inc.).
- Segment focus: Nabtesco Corporation has 4 segments (34.2% in Component Solutions Business); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Quasi-Monopoly vs Competitive. Pricing power: Strong vs Moderate.
- Moat breadth: Nabtesco Corporation has 5 moat types across 3 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
Nabtesco Corporation
Component Solutions Business
Precision reduction gears (RV reducers) for industrial robot joints
Global
Industrial robot manufacturers (OEMs)
Precision motion-control component supplier
34.2%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Nabtesco Corporation strengths
Merck & Co., Inc. strengths
Segment mix
Nabtesco Corporation segments
Full profile >Component Solutions Business
Quasi-Monopoly
Transport Solutions Business
Oligopoly
Accessibility Solutions Business
Quasi-Monopoly
Other Businesses
Quasi-Monopoly
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.